IPO Plus

₹1,161

▼ -26.85 -2.26%

As of 06 Nov 2026 · delayed

NSE Listed · Pharmaceuticals

Senores Pharmaceuticals Limited (SENORES)

Volume: 2,74,945Avg Vol 1W: 3,22,223Avg Vol 1M: 3,62,76652W Range:₹706₹1,599
NSE BSE www.senorespharma.com AI Report
Key Ratios
Checked just now
Market Cap₹5,347 Cr
Current Price₹1,161
Previous Close₹1,187.85
High / Low (52w)₹1,599 / ₹706
Volume2,74,945
Avg Vol (1W)3,22,223
Avg Vol (1M)3,62,766
Stock P/E40.06
Book Value₹217.79
Dividend Yield0%
ROE13.31%
ROA8.17%
Revenue (TTM)—
Revenue Growth85.65%
Profit Margin18.57%
Total Debt₹162 Cr
Shares Outstanding5 Cr
Face Value₹10
EPS (TTM)₹28.98
P/B5.33
Debt / Equity0.38
50 DMA₹1,342.92
200 DMA₹1,122.58
Day change-2.26%
Price Chart
₹1,161▲ 41.08% · 1Y
₹1551₹60746.0L
2025-11-07
2026-11-06

20-day avg volume: 3.7L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 32% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Revenue₹103 Cr₹114 Cr₹138 Cr₹162 Cr₹171 Cr₹175 Cr₹180 Cr₹192 Cr
EBITDA₹27 Cr₹26 Cr₹32 Cr₹47 Cr₹50 Cr₹56 Cr₹47 Cr₹56 Cr
Net Profit₹17 Cr₹18 Cr₹20 Cr₹32 Cr₹32 Cr₹32 Cr₹31 Cr₹39 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026Sept 2026
Revenue₹12 Cr₹16 Cr₹28 Cr₹25 Cr₹680 Cr₹37 Cr₹27 Cr₹36 Cr
EBITDA₹5 Cr₹5 Cr₹9 Cr₹5 Cr₹184 Cr₹15 Cr₹4 Cr₹12 Cr
Net Profit₹2 Cr₹3 Cr₹6 Cr₹3 Cr₹115 Cr₹8 Cr₹1 Cr₹8 Cr
EPS————26.39———
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹15 Cr₹59 Cr₹131 Cr₹622 Cr₹1,227 Cr₹1,604 Cr
Total Liabilities₹5 Cr₹23 Cr₹86 Cr₹390 Cr₹415 Cr₹639 Cr
Equity₹9 Cr₹37 Cr₹45 Cr₹232 Cr₹812 Cr₹965 Cr
Total Debt₹3 Cr—————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-3 Cr₹-10 Cr₹0 Cr₹-23 Cr₹-37 Cr₹75 Cr
Investing₹-4 Cr₹-24 Cr₹-48 Cr₹-54 Cr₹-429 Cr₹-121 Cr
Financing₹8 Cr₹36 Cr₹46 Cr₹87 Cr₹573 Cr₹-1 Cr
Free Cash Flow₹-6 Cr₹-10 Cr₹0 Cr₹-23 Cr₹-37 Cr₹75 Cr
Shareholding
Promoter 45.82% Institutions 16.85% Public 37.33%
Efficiency & Working Capital
ROCE14.7%
Interest Coverage7.4
Dividend Payout—
Debtor Days187 d
Inventory Days52 d
Payable Days135 d
Cash Conversion Cycle104 d
Working Capital Days239 d
Shareholding Details

As of 2026-09-30

Promoter45.8%
FII6%
DII10.8%
Institutions16.9%
Public37.3%
Promoter Pledge2.8%
No. of Shareholders42,642
Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

PeriodJul 2024Jul 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters66.7%66.7%45.8%45.8%45.8%45.8%45.8%45.8%45.8%45.8%45.8%
FIIs0%0%5.5%4.3%4.2%3.7%4.3%3.3%3.6%6.6%6%
DIIs33.3%0%18.6%11.8%9.7%9.5%8.6%9.3%9.6%9.8%10.8%
Public0%33.3%30.1%38.2%40.4%41%41.3%41.5%40.9%37.8%37.3%
Promoter Pledge0%0%0%0%0%0%0%1.9%1.9%2.8%2.8%
No. of Shareholders17717743,70749,51837,65336,38934,91734,40134,12636,49842,642
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Swapnil Jatin ShahShareholding of Promoter and Promoter Group7.7%35,53,531
Ashokbhai Vijaysinh BarotShareholding of Promoter and Promoter Group7.6%34,74,869
Remus Pharmaceuticals LimitedShareholding of Promoter and Promoter Group7.1%32,61,744
Renosen Pharmaceuticals Private LimitedShareholding of Promoter and Promoter Group5.9%27,18,719
Anar Swapnil ShahShareholding of Promoter and Promoter Group5%22,94,500
Aviraj Overseas LlcShareholding of Promoter and Promoter Group4.1%18,95,190
Hsbc Mutual Fund - Hsbc Multi Cap FundPublic Shareholding2.9%13,19,537
Sangeeta Mukur BarotShareholding of Promoter and Promoter Group2.3%10,42,955
Manoj Prakash SanghviPublic Shareholding1.9%8,54,484
Ratnamani Marketing Private LimitedPublic Shareholding1.8%8,38,000
Bajaj Finserv Flexi Cap FundPublic Shareholding1.8%8,24,939
Aviraj Group LlcShareholding of Promoter and Promoter Group1.5%6,84,750
Astorne Capital Vcc - ArvenPublic Shareholding1.4%6,28,528
Aditya Birla Sun Life Insurance Company LimitedPublic Shareholding1.3%5,89,268
Jayanti Mishrimal Sanghvi .Public Shareholding1.2%5,67,823
Trustmf Small Cap FundPublic Shareholding1.2%5,66,901
Mahindra Manulife Innovation Opportunities FundPublic Shareholding1.2%5,55,600
Jigar Prakash SanghviPublic Shareholding1.2%5,49,523
Espee Therapeutics LlpShareholding of Promoter and Promoter Group1.1%4,95,000
Jitendra Babulal SanghviShareholding of Promoter and Promoter Group1.1%4,88,516
Prakash Mishrimal SanghviPublic Shareholding1%4,76,190
Mukur Yogeshkumar BarotShareholding of Promoter and Promoter Group1%4,56,825
Shantaben Babulal SanghviShareholding of Promoter and Promoter Group0.7%3,28,569
Dhananjay Ashokkumar BarotShareholding of Promoter and Promoter Group0.6%2,82,689
Hemant Ishwarlal ModiShareholding of Promoter and Promoter Group0.1%62,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Mukur Yogeshkumar Barot1,93,00042.3%2026-09-30
Board of Directors
NameDesignationYear
SWAPNIL JATINBHAI SHAHManaging Director2025
Sanjay MajmudarChairman (Non-Executive)2025
Hemanshu Nitinchandra PandyaNon Executive Director2025
Jitendra Babulal SanghviIndependent Director2025
Chetan Bipinchandra ShahWhole Time Director & Chief Operating Officer2025
Deval Rajnikant ShahWhole Time Director & Chief Financial Officer2025
Ashokkumar Vijaysinh BarotNon Executive Director2025
ARPIT DEEPAKKUMAR SHAHNon Executive Director2025
Naresh Bansilal ShahIndependent Director2025
Manjula Devi ShroffIndependent Director2025
Kalpit Rajesh GandhiIndependent Director2025
Udayan ChoksiIndependent Director2025
Segments — Geography
RegionRevenueShare
Within India₹22 Cr56.7%
Outside India₹17 Cr43.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10544646
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-27Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202400069287367
202400065233308
2024000000
Insider / Designated-Person Trades

16 recent disclosure(s)

ASHOKKUMAR VIJAYSINH BAROTAcquisition · 30,000
DHANANJAY ASHOKKUMAR BAROTDisposal · 30,000
ASHOKKUMAR VIJAYSINH BAROTAcquisition · 30,000
DHANANJAY ASHOKKUMAR BAROTDisposal · 30,000
ASHOKKUMAR VIJAYSINH BAROTAcquisition · 30,000
DHANANJAY ASHOKKUMAR BAROTDisposal · 30,000
Substantial Acquisitions (SAST)

4 disclosure(s)

Off Market / Inter se transfer10/08/2026 · 30,000
Off Market / Inter se transfer10/08/2026 · 30,000
Market31/12/2025 · 6,000
Market17/12/2025 · 4,000
Company Information
Incorporated2017
ChairmanSanjay Majmudar
AuditorPankaj R Shah & Associates/Talati & Talati LLP
Investor Email[email protected]
🌐 www.senorespharma.com ↗

📍 #.1101-1103 11th Flr South Twr, Ambali Bopal Road, Ahmedabad, Gujarat, 380054

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Saint Gobain Sekur Ind LimitedSungarner Energies Ltd.Sellowrap Industries Ltd.SEL Manufacturing Company Ltd.Semac Construction Ltd.Senco Gold LimitedSEPC LimitedService Care LimitedServotech Renewable Power System Ltd.Seshasayee Paper & Boards Ltd.Setco Automotive Ltd.Standard Engineering Technology Ltd.All “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App